Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis. （開啟新視窗）

Chai-Adisaksopha C, Hillis C, Siegal DM, Movilla R, Heddle N, Iorio A, Crowther M.

來源‎: Thromb Haemost 2016;116(5):879-90.

檢索‎: PubMed 27488143

DOI碼‎: 10.1160/TH16-04-0266

https://www.ncbi.nlm.nih.gov/pubmed/27488143 （開啟新視窗）

Pharmacological prophylaxis of bleeding in surgical patients treated with aspirin. （開啟新視窗）

Flordal PA.

來源‎: Eur J Anaesthesiol Suppl 1997;14:38-41.

檢索‎: PubMed 9088834

https://www.ncbi.nlm.nih.gov/pubmed/9088834 （開啟新視窗）

Reversal of warfarin: case-based practice recommendations. （開啟新視窗）

Garcia DA, Crowther MA.

來源‎: Circulation 2012;125(23):2944-7.

檢索‎: PubMed 22689931

DOI碼‎: 10.1161/CIRCULATIONAHA.111.081489

https://www.ncbi.nlm.nih.gov/pubmed/22689931 （開啟新視窗）

Stopping antiplatelet medication before coronary artery bypass graft surgery: is there an optimal timing to minimize bleeding? （開啟新視窗）

Gielen CL, Bruggemans EF, Stijnen T, Eikenboom J, Tavilla G, Brand A, Klautz RJ.

來源‎: Eur J Cardiothorac Surg 2015;48(4):e64-70.

檢索‎: PubMed 26248820

DOI碼‎: 10.1093/ejcts/ezv269

https://www.ncbi.nlm.nih.gov/pubmed/26248820 （開啟新視窗）

Is a fully heparin-bonded cardiopulmonary bypass circuit superior to a standard cardiopulmonary bypass circuit? （開啟新視窗）

Mahmood S, Bilal H, Zaman M, Tang A.

來源‎: Interact Cardiovasc Thorac Surg 2012;14(4):406-14.

檢索‎: PubMed 22228288

DOI碼‎: 10.1093/icvts/ivr124

https://www.ncbi.nlm.nih.gov/pubmed/22228288 （開啟新視窗）

Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes. （開啟新視窗）

Mangoush O, Purkayastha S, Haj-Yahia S, Kinross J, Hayward M, Bartolozzi F, Darzi A, Athanasiou T.

來源‎: Eur J Cardiothorac Surg 2007;31(6):1058-69.

檢索‎: PubMed 17306555

DOI碼‎: 10.1016/j.ejcts.2007.01.029

https://www.ncbi.nlm.nih.gov/pubmed/17306555 （開啟新視窗）

Heparin-coated extracorporeal circulation in combination with low dose systemic heparinization reduces early postoperative blood loss in cardiac surgery. （開啟新視窗）

Mirow N, Zittermann A, Koertke H, Maleszka A, Knobl H, Coskun T, Kleesiek K, Koerfer R.

來源‎: J Cardiovasc Surg (Torino) 2008;49(2):277-84.

檢索‎: PubMed 18431350

https://www.ncbi.nlm.nih.gov/pubmed/18431350 （開啟新視窗）

Idarucizumab for dabigatran reversal. （開啟新視窗）

Pollack CV Jr, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kamphuisen PW, Kreuzer J, Levy JH, Sellke FW, Stangier J, Steiner T, Wang B, Kam CW, Weitz JI.

來源‎: N Engl J Med 2015;373(6):511-20.

檢索‎: PubMed 26095746

DOI碼‎: 10.1056/NEJMoa1502000

https://www.ncbi.nlm.nih.gov/pubmed/26095746 （開啟新視窗）

Idarucizumab for dabigatran reversal - full cohort analysis. （開啟新視窗）

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

來源‎: N Engl J Med 2017;377(5):431-41.

檢索‎: PubMed 28693366

DOI碼‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 （開啟新視窗）

Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy. （開啟新視窗）

Ranucci M, Nano G, Pazzaglia A, Bianchi P, Casana R, Tealdi DG.

來源‎: J Cardiothorac Vasc Anesth 2007;21(6):851-4.

檢索‎: PubMed 18068065

DOI碼‎: 10.1053/j.jvca.2007.05.009

https://www.ncbi.nlm.nih.gov/pubmed/18068065 （開啟新視窗）

Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. （開啟新視窗）

Sarode R, Milling TJ Jr, Refaai MA, Mangione A, Schneider A, Durn BL, Goldstein JN.

來源‎: Circulation 2013;128(11):1234-43.

檢索‎: PubMed 23935011

DOI碼‎: 10.1161/CIRCULATIONAHA.113.002283

https://www.ncbi.nlm.nih.gov/pubmed/23935011 （開啟新視窗）

Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. （開啟新視窗）

Shi J, Ji H, Ren F, Wang G, Xu M, Xue Y, Chen M, Qi J, Li L.

來源‎: JAMA Surg 2013;148(6):538-47.

檢索‎: PubMed 23426385

DOI碼‎: 10.1001/jamasurg.2013.1560

https://www.ncbi.nlm.nih.gov/pubmed/23426385 （開啟新視窗）

Andexanet alfa for the reversal of Factor Xa inhibitor activity. （開啟新視窗）

Siegal DM, Curnutte JT, Connolly SJ, Lu G, Conley PB, Wiens BL, Mathur VS, Castillo J, Bronson MD, Leeds JM, Mar FA, Gold A, Crowther MA.

來源‎: N Engl J Med 2015;373(25):2413-24.

檢索‎: PubMed 26559317

DOI碼‎: 10.1056/NEJMoa1510991

https://www.ncbi.nlm.nih.gov/pubmed/26559317 （開啟新視窗）

Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. （開啟新視窗）

Warkentin TE, Margetts P, Connolly SJ, Lamy A, Ricci C, Eikelboom JW.

來源‎: Blood 2012;119(9):2172-4.

檢索‎: PubMed 22383791

DOI碼‎: 10.1182/blood-2011-11-393587

https://www.ncbi.nlm.nih.gov/pubmed/22383791 （開啟新視窗）

Heparinized cardiopulmonary bypass circuits and low systemic anticoagulation: an analysis of nearly 6000 patients undergoing coronary artery bypass grafting. （開啟新視窗）

Øvrum E, Tangen G, Tølløfsrud S, Skeie B, Ringdal MA, Istad R, Øystese R.

來源‎: J Thorac Cardiovasc Surg 2011;141(5):1145-9.

檢索‎: PubMed 20709334

DOI碼‎: 10.1016/j.jtcvs.2010.07.003

https://www.ncbi.nlm.nih.gov/pubmed/20709334 （開啟新視窗）